Optimal use of bisphosphonates in patients with multiple myeloma.

نویسندگان

  • Evangelos Terpos
  • G David Roodman
  • Meletios A Dimopoulos
چکیده

A 71-year-old woman presented with extreme low back pain. Her lumbar spine radiographs revealed a pathological fracture of L4. The hematology profile was normal (hemoglobin: 12.6 g/dL). The serum electrophoresis revealed an “M”-protein of 39 g/L and the immunofixation showed an immunoglobulin (Ig) G-l paraprotein. The bone marrow trephine biopsy demonstrated a clonal plasma-cell infiltration of 35%. The diagnosis of IgG-l multiple myeloma was made. The skeletal survey using conventional radiography showed an L4 fracture but no lytic lesions in the skeleton. The magnetic resonance imaging (MRI) of the lumbar spine and the pelvis revealed a diffuse pattern of marrow infiltration. The patient had normal creatinine (1.1 mg/dL; estimated glomerular filtration rate by Chronic Kidney Disease Epidemiology Collaboration formula was 51 mL/min/1.73 m) and normal serum calcium (9.9 mg/dL) levels. How should we manage bone disease in this myeloma patient?

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A Rare Presentation of Multiple Myeloma: A Case Report of Hepatic Amyloidosis

The clinically reported case of liver involvement with multiple myeloma (MM) is rare. Amyloidosis, defined as a tissue deposition of clonal light-chain fibrils, has been reported in 10-15% of the MM patients. We described a rare MM patient with the primal presentation of fulminant hepatic failure and biliary system involvement due to amyloidosis. Our patient had the primal symptoms of hyperbili...

متن کامل

Clinical trials of bisphosphonates in multiple myeloma.

More than 80% of patients with multiple myeloma (MM) have osteolytic bone disease, which increases the risk of skeletal-related events (SREs) such as pathologic fracture, spinal cord compression, and the need for radiotherapy or surgery. Bone disease is primarily due to increased osteoclastic activity and impaired osteoblast activity. Bisphosphonates are pyrophosphate analogues with high bone a...

متن کامل

In vitro Effect of Pomalidomide on Bone Marrow Mononuclear Cells from Multiple Myeloma Patients

Background: Many features of anticancer drugs, including cytotoxicity and/or cytokine induction, are studied using cell lines orhuman blood leukocytes. However, in a disease such as multiple myeloma, most cancerous cells are resided within bone marrowmononuclear cells. In the present study, we investigated the effect of pomalidomide on apoptosis and IL-2 production of bonemarrow mononuclear cel...

متن کامل

ELECTRODIAGNOSTIC STU DY OF PERIPHERAL NERVOUS SYSTEM (PNS) IN 30 PATIENTS WITH MULTIPLE MYELOMA

Involvement of the peripheral nervous system is one of the complications of multiple myeloma with a varying incidence of clinical and subclinical neuropathy in different studies. As most of the patients with multiple myeloma suffer from generalized systemic symptoms such as malaise, bone and low back pain, the clinical clues to the diagnosis of the neuropathy in its initial stages could be ...

متن کامل

Bilateral Atypical Femoral Fractures in a Patient with Multiple Myeloma Treated with Intravenous Bisphosphonate Therapy

Bisphosphonates are currently the standard approach to managing bone disease in multiple myeloma. Bisphosphonates have high bone affinity that inhibits osteoclastic activity and additionally reduces the growth factors released from malignant or osteoblastic cells, thereby impairing abnormal bone remodeling which leads to osteolysis. However, patients of multiple myeloma may be at a higher risk ...

متن کامل

Methylation Status of SMG1 Gene Promoter in Multiple Myeloma

Background: Epigenetic modifications, such as methylation can occur in multiple myeloma. SMG1is an important gene involved in cell growth which defect in methylation of its promoter leads to reduction of cell apoptosis and uncontrolled proliferation. In this study, we identified the methylation status of the SMG1 gene promoter in patients with multiple myeloma. Methods: Methylation status of S...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Blood

دوره 121 17  شماره 

صفحات  -

تاریخ انتشار 2013